- Home
- DTI vs ADAG Comparison
DTI vs ADAG Comparison
Compare DTI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- ADAG
- Stock Information
- Founded
- DTI 1984
- ADAG 2011
- Country
- DTI United States
- ADAG China
- Employees
- DTI N/A
- ADAG N/A
- Industry
- DTI Metal Fabrications
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- ADAG Health Care
- Exchange
- DTI Nasdaq
- ADAG Nasdaq
- Market Cap
- DTI 114.9M
- ADAG 95.6M
- IPO Year
- DTI N/A
- ADAG 2021
- Fundamental
- Price
- DTI $3.49
- ADAG $2.14
- Analyst Decision
- DTI Strong Buy
- ADAG Strong Buy
- Analyst Count
- DTI 1
- ADAG 1
- Target Price
- DTI $5.50
- ADAG $5.00
- AVG Volume (30 Days)
- DTI 62.4K
- ADAG 73.9K
- Earning Date
- DTI 11-13-2024
- ADAG 07-25-2024
- Dividend Yield
- DTI N/A
- ADAG N/A
- EPS Growth
- DTI N/A
- ADAG N/A
- EPS
- DTI 0.26
- ADAG N/A
- Revenue
- DTI $149,789,000.00
- ADAG $815,746.00
- Revenue This Year
- DTI $7.05
- ADAG N/A
- Revenue Next Year
- DTI $14.10
- ADAG $2.70
- P/E Ratio
- DTI $13.15
- ADAG N/A
- Revenue Growth
- DTI N/A
- ADAG N/A
- 52 Week Low
- DTI $2.43
- ADAG $1.34
- 52 Week High
- DTI $6.36
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- DTI 50.38
- ADAG 37.47
- Support Level
- DTI $3.06
- ADAG $2.20
- Resistance Level
- DTI $3.54
- ADAG $3.14
- Average True Range (ATR)
- DTI 0.18
- ADAG 0.30
- MACD
- DTI 0.04
- ADAG -0.09
- Stochastic Oscillator
- DTI 85.00
- ADAG 18.63
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The Company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The Company's international operations are located in Canada with additional stocking points in Europe and the Middle East.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.